Exclusive

Publication

Byline

Location

Clinical Trial: HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07575308) titled 'HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With V... Read More


Clinical Trial: CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07575893) titled 'CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma' on May 04. Brief Summary:... Read More


Clinical Trial: Low Blood Flow Restriction Training on Low Back Pain

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07576101) titled 'Low Blood Flow Restriction Training on Low Back Pain' on May 04. Brief Summary: The aim of t... Read More


Clinical Trial: Familia Imara: A Parenting Program to Reduce Family Violence in Tanzania

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07574567) titled 'Familia Imara: A Parenting Program to Reduce Family Violence in Tanzania' on May 01. Brief S... Read More


Clinical Trial: Subcostal Transversus Abdominis Plane Block

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07576712) titled 'Subcostal Transversus Abdominis Plane Block' on May 01. Brief Summary: This non-randomized c... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and E... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and T... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post... Read More